Personalized cancer treatment study
This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (not a blood cancer)
- Standard treatment options are no longer available or effective for you
- You are physically active and able to care for yourself (performance status 0-1)
- You have a tumor that can be biopsied (sample taken) and is measurable
- You are willing to provide informed consent
- You have a life expectancy of at least 3 months and adequate organ function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This study looks at your tumor’s genetic information to help match you to targeted treatments when standard options are no longer working. You may be offered options based on results, with the goal of helping people with incurable, worsening cancer.
This trial tests whether using a personalized approach (matching your tumor's genetic profile to a targeted drug) can help people with advanced solid cancers live longer. It is for people whose cancer is not responding to standard treatments and who have a genetic change that can be targeted by an FDA-approved drug not usually used for their cancer type.
This study aims to create personalized models (like miniature tumors in a dish) from your cells to better understand your cancer and find new ways to treat it. Both people with solid tumors and healthy volunteers are welcome to participate.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Hear when a new Unspecified Adult Solid Tumor, Protocol Specific trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.